Tempest Therapeutics Statistics
Total Valuation
TPST has a market cap or net worth of $18.07 million. The enterprise value is $24.12 million.
| Market Cap | 18.07M |
| Enterprise Value | 24.12M |
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPST has 14.34 million shares outstanding. The number of shares has increased by 133.63% in one year.
| Current Share Class | 14.34M |
| Shares Outstanding | 14.34M |
| Shares Change (YoY) | +133.63% |
| Shares Change (QoQ) | +122.77% |
| Owned by Insiders (%) | 33.77% |
| Owned by Institutions (%) | 5.22% |
| Float | 9.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 21.99 |
| P/TBV Ratio | 21.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 9.55.
| Current Ratio | 0.74 |
| Quick Ratio | 0.55 |
| Debt / Equity | 9.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -460.39 |
Financial Efficiency
Return on equity (ROE) is -721.00% and return on invested capital (ROIC) is -80.43%.
| Return on Equity (ROE) | -721.00% |
| Return on Assets (ROA) | -61.69% |
| Return on Invested Capital (ROIC) | -80.43% |
| Return on Capital Employed (ROCE) | -284.77% |
| Weighted Average Cost of Capital (WACC) | -3.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.77M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.13% in the last 52 weeks. The beta is -1.78, so TPST's price volatility has been lower than the market average.
| Beta (5Y) | -1.78 |
| 52-Week Price Change | -83.13% |
| 50-Day Moving Average | 1.75 |
| 200-Day Moving Average | 4.66 |
| Relative Strength Index (RSI) | 30.11 |
| Average Volume (20 Days) | 107,563 |
Short Selling Information
The latest short interest is 341,334, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 341,334 |
| Short Previous Month | 401,128 |
| Short % of Shares Out | 2.38% |
| Short % of Float | 3.68% |
| Short Ratio (days to cover) | 1.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.18M |
| Pretax Income | -43.10M |
| Net Income | -43.10M |
| EBITDA | -20.92M |
| EBIT | -21.18M |
| Earnings Per Share (EPS) | -$7.16 |
Balance Sheet
The company has $1.81 million in cash and $7.85 million in debt, with a net cash position of -$6.05 million or -$0.42 per share.
| Cash & Cash Equivalents | 1.81M |
| Total Debt | 7.85M |
| Net Cash | -6.05M |
| Net Cash Per Share | -$0.42 |
| Equity (Book Value) | 822,000 |
| Book Value Per Share | 0.06 |
| Working Capital | -865,000 |
Cash Flow
| Operating Cash Flow | -26.38M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 258,000 |
| Net Borrowing | -4.23M |
| Free Cash Flow | -26.38M |
| FCF Per Share | -$1.84 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -133.63% |
| Shareholder Yield | -133.63% |
| Earnings Yield | -238.46% |
| FCF Yield | -145.97% |
Analyst Forecast
The average price target for TPST is $11.00, which is 773.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 773.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:13.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:13 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |